Uwe Siegler

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

Stefan Diermayr, Heike Himmelreich, Bojana Müller-Durovic et al. · Blood · 2007 · 214 citations

Life Sciences, Cell Biology, Immunology +16

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis

A Rohner, Ulrich Langenkamp, Uwe Siegler et al. · Leukemia Research · 2007 · 107 citations

Life Sciences, Immunology, Oncology +13

Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients

Uwe Siegler, Sandrine Meyer‐Monard, Simon Jörger et al. · Cytotherapy · 2010 · 91 citations

Life Sciences, Cell Biology, Immunology +16

Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice

Uwe Siegler, Christian P. Kalberer, Pegah Nowbakht et al. · Leukemia · 2005 · 60 citations

Life Sciences, Hematology, Immunology +9

Clinical‐grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation

Sandrine Meyer‐Monard, Jakob Passweg, Uwe Siegler et al. · Transfusion · 2008 · 49 citations · Full text

Life Sciences, Hematology, Immunology +14